Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-05-07 @ 11:26 AM
Study NCT ID:
NCT02896192
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2016-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity
Sponsor:
Rhythm Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RM-493-012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None